(0.34%) 5 108.75 points
(0.71%) 38 654 points
(0.65%) 17 764 points
(0.15%) $79.07
(0.20%) $2.04
(-0.08%) $2 307.80
(-0.26%) $26.76
(1.19%) $974.10
(-0.14%) $0.931
(-0.59%) $10.93
(-0.22%) $0.796
(0.51%) $91.59
0.00% $ 0.000800
Live Chart Being Loaded With Signals
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...
Stats | |
---|---|
Volumen de hoy | 13.19M |
Volumen promedio | 4.39M |
Capitalización de mercado | 2.63B |
EPS | $-0.0449 ( 2023-11-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0800 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-07-05 | Zelinger Josef | Buy | 15 000 000 | Common Stock Purchase Warrant |
2021-08-17 | Kenyon Julian Norman | Buy | 3 420 000 | Common stock, par value $0.001 |
2021-08-17 | Nathanielsz James Andrew | Buy | 5 928 000 | Common stock, par value $0.001 |
2021-08-17 | Nathanielsz James Andrew | Buy | 2 800 000 | Common stock, par value $0.001 |
2021-08-17 | Zelinger Josef | Sell | 0 | Common stock, par value $0.001 |
INSIDER POWER |
---|
100.00 |
Last 22 transactions |
Buy: 280 061 820 | Sell: 580 500 |
Propanc Biopharma, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Propanc Biopharma, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-28 841.00 (0.00 %) |
EPS: | $-1.530 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-28 841.00 (0.00 %) |
EPS: | $-1.530 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-28 366.00 (0.00 %) |
EPS: | $-1.530 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.800 |
Financial Reports:
No articles found.
Propanc Biopharma, Inc.
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico